MLchartDataset catalogue

Daniquidone

Term · Oncology and biomedicine · MLC-T-ONC-012911

A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent.

Table 1. Record
IdentifierMLC-T-ONC-012911
FieldOncology and biomedicine
Synonymsbatracylin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012911",
  "term": "Daniquidone",
  "field": "Oncology and biomedicine",
  "definition": "A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent.",
  "synonyms": [
    "batracylin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/daniquidone/"
}

Record 5,677 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.